Disc Medicine Inc
(IRON)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,969 | -54,046 | -35,495 | -19,048 | -40,837 |
| Depreciation Amortization | 32 | 185 | 127 | 65 | 322 |
| Accounts payable and accrued liabilities | 1,315 | -459 | 42 | 2,173 | -2,408 |
| Other Working Capital | 1,286 | -1,853 | -2,558 | -116 | 337 |
| Other Operating Activity | 5,802 | 9,141 | 6,949 | 1,919 | 9,878 |
| Operating Cash Flow | $-27,534 | $-47,032 | $-30,935 | $-15,007 | $-32,708 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -68 | -61 | N/A | N/A | -22 |
| Investing Cash Flow | $-68 | $-61 | $N/A | $N/A | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -3,333 | -2,083 | -833 | 14,000 |
| Common Stock Issued | 68 | 110 | 110 | 4 | 163 |
| Other Financing Activity | 89,861 | 195,882 | 195,882 | 196,319 | 20,084 |
| Financing Cash Flow | $89,929 | $192,659 | $193,909 | $195,490 | $34,247 |
| Beginning Cash Position | 25,886 | 4,826 | 4,826 | 4,826 | 3,309 |
| End Cash Position | 88,213 | 150,392 | 167,800 | 185,309 | 4,826 |
| Net Cash Flow | $62,327 | $145,566 | $162,974 | $180,483 | $1,517 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,534 | -47,032 | -30,935 | -15,007 | -32,708 |
| Capital Expenditure | -68 | -61 | N/A | N/A | -22 |
| Free Cash Flow | -27,602 | -47,093 | -30,935 | -15,007 | -32,730 |